Should I buy Home BancShares (HOMB) stock or is it too late?

Home BancShares · Financials · price $28

See the full Home BancShares (HOMB) profile

⭐ What the most reliable analysts say · those who beat their sector, targets replayed on real prices

⭐ The most reliable of them, either direction: Piper Sandler — 72% of its targets hit on this sector (239 calls tested). It aims for $36 (+27 %), call made on July 18, 2026, maturing on July 18, 2027 (88 d ago).

The 4 reliable analysts $33.50+18 %

The 2 other firms $32.50+15 %

How to read it: the 4 reliable firms are not filtered by optimism — 4 aim above the price, 0 below, hence their $33.50 median. “The 2 others” are the firms that don't pass our reliability filter on this sector.

Firm-by-firm track record on Home BancShares

Here the hit rate is measured <b>on this stock specifically</b> (matured targets replayed against real prices, minimum 5 calls tested) — the green block above measures reliability <b>across the whole sector</b>, which is the criterion behind JPI selections. “Aims for” = the firm's most recent target on this stock; “—” means it hasn't published one recently.

Firm	% right	Gain vs sector	Calls	Aims for
Raymond James	71 %	+27.8 %	7	$30 +6%
Stephens & Co.	77 %	+15.6 %	13	$35 +23%
Keefe, Bruyette & Woods	80 %	+13.0 %	5	$32 +13%
Piper Sandler	73 %	+11.0 %	11	$36 +27%
Wunderlich Securities	88 %	+51.9 %	8	—

In short — Should you invest in Home BancShares? Is it too late, still worth it? Analysts are split (43% buy, median target $33, i.e. +16%), and the most reliable on HOMB targets even higher. We give you both sides, with the numbers — not advice.

✅ Reasons to believe

Median price target $33, i.e. +16% from the current price ($28).
The most reliable firm on HOMB, Keefe, Bruyette & Woods (80% hit rate, 5 scored calls), targets $32 (call made on July 17, 2026, maturing on July 17, 2027) (+13%) in its most recent call, and $30 (call made on April 20, 2026, maturing on April 20, 2027) (+6%) in the one coming due soonest.
Pays a dividend (2.9% yield), raised for 15 years — regular income on top of potential upside.

⚠️ Reasons to hesitate

The consensus is not unanimous: of 7 ratings, 4 are neutral.
A 12-month target is not a guaranteed path: the price can fall in the meantime.

The analyst consensus on HOMB

Median target $33 (+16%) · 7 ratings · Hold consensus

Strong Buy00%

Buy343%

Hold457%

Sell00%

Strong Sell00%

⚠️ Information, not investment advice. Past performance does not guarantee future results. Analyst targets on a ~12-month horizon.

Frequently asked questions

Should you invest in Home BancShares now?

We won't decide for you. The facts: 43% of analysts rate it a buy, median target $33 (+16%), and Keefe, Bruyette & Woods (most reliable on HOMB, 80%) targets $32. Weigh that against valuation. This is not personalized advice.

Is it too late to invest in Home BancShares?

Not according to analysts: the median target ($33) is still +16% above the current price ($28) (most reliable on HOMB: Keefe, Bruyette & Woods, 80%). The real question isn't "too late" but the price-to-value gap and risk. Not advice.

Is Home BancShares still worth investing in?

It depends on the gap between the price ($28) and its estimated value: analysts target $33 on median (+16%), with 43% buys (most reliable on HOMB: Keefe, Bruyette & Woods, 80%). Cross-check with their real reliability on HOMB and the cautions above. Information, not advice.

What's the main risk in buying HOMB?

The consensus is not unanimous: of 7 ratings, 4 are neutral.

→ Go deeper: the full Home BancShares profile (consensus, analyst reliability, price target, performance).